TrialGynecologic oncology2021

Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial.

Nicoletta Colombo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.